Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine (multiple letters)

Cancer

Volumn 104, Issue 5, 2005, Pages 1110-1111

  Barceló, Ramón ^a   Munoz, Alberto ^a   López Vivanco, Guillermo ^a   Numico, Gianmauro ^b   Merlano, Marco ^b   Silvestris, Nicola ^c  

^a HOSPITAL DE CRUCES   (Spain)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c SANTA MARIA GORETTI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE;

CANCER COMBINATION CHEMOTHERAPY; EVALUATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; INCIDENCE; ISCHEMIA; LETTER; LIVER VENOOCCLUSIVE DISEASE; LUNG NON SMALL CELL CANCER; LUNG VEIN OBSTRUCTION; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; VASCULAR DISEASE; VASCULITIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; HUMANS; LUNG NEOPLASMS; THROMBOSIS;

EID: 23844436984     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21328     Document Type: Letter

References (0)